Celebrating our 10th anniversary – Unlock our special offer today

So far so good, but German lawmakers urged to go further on medical cannabis

Five years after German patients were first allowed to obtain medical cannabis, demand has risen sharply but there are still some unanswered issues on policy and practice that lobbyists want addressed.

A unanimous decision by lawmakers in the Bundestag permitted doctors to prescribe medical cannabis from 10th March 2017. “The law was a big step forward, but now it is time for improvements,” said Armin Prasch, a board member of Germany’s Cannabis Business Industry Association (Branchenverband Cannabiswirtschaft, BvCW).

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization